Latest California Healthline Stories
Experimental Alzheimer’s Drug Potential ‘Game Changer’ In Fight Against Disease
Scientists say they are cautiously optimistic with results from a trial of the new drug, which targets the dangerous plaques that build up in the brain — a hallmark of Alzheimer’s.
Why Are Drug Companies Raising Prices? Because They Can
The Los Angeles Times looks at why generics aren’t helping moderate the marketplace.
Bill Setting Standards For Manufacturing Medical Marijuana Sent To Governor
In other news, adults’ attitudes toward marijuana are shifting, a new analysis finds.
Measure To Protect Patients From Surprise Medical Bills Clears Both State Houses
Under the legislation, the consumer would pay only what an in-network provider would charge.
The Zika Coffers Are Bare, CDC Director Warns
If the virus starts spreading more broadly within the country, the agency says its hands will be tied as its financial resources will run out next month.
Stress Related To Housing Insecurity A Public Health Crisis In Oakland
Most notably, officials are worried about rapidly increasing asthma and hypertension rates.
Doctor Establishes Trust By Embracing Patients’ Cultural Beliefs
“If we don’t address cultural beliefs, a patient may be less willing to accept the medical provider’s explanation of a disease or condition and follow a prescribed treatment,” Dr. Enrique Gonzalez-Mendez says.
Theranos Withdraws Zika Test Application After FDA Finds Fault With Safety Measures
It’s just the latest blow to the struggling Palo Alto company.
Media Exemption Smoothes Way For Deal On Planned Parenthood-Sponsored Bill
The measure tightens regulations on secret videos in the wake of the ones of Planned Parenthood employees that were distributed last year.
With EpiPen Controversy Roiling, Lawmaker Renews Crusade Against High Drug Costs
State Sen. Ed Hernandez’s drug pricing transparency bill faltered, but that hasn’t stopped him from introducing a measure to urge Congress to investigate EpiPen maker Mylan.